Key result
Warfarin and aspirin are evaluated for their therapeutic role in patients with non-rheumatic atrial fibrillation.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Informs antithrombotic choices in non-rheumatic AF; extends RCT evidence for stroke prevention.
Non-rheumatic atrial fibrillation: warfarin or aspirin
No takes yet. Share an insight, caveat, or question.
Nolan et al. (1992) studied this question. Warfarin and aspirin are evaluated for their therapeutic role in patients with non-rheumatic atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: